Risk prediction models for mortality in ambulatory patients with heart failure a systematic review

Circulation: Heart Failure

Volumn 6, Issue 5, 2013, Pages 881-889

  Alba, Ana C ^a   Agoritsas, Thomas ^b   Jankowski, Milosz ^c   Courvoisier, Delphine ^d   Walter, Stephen D ^b   Guyatt, Gordon H ^b   Ross, Heather J ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

Heart failure; Prediction models; Prognosis; Survival

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POTASSIUM SPARING DIURETIC AGENT;

6 MINUTE WALK TEST; AMBULATORY CARE; ARTICLE; CALIBRATION; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; EXERCISE TEST; HEART FAILURE; HEART FAILURE SURVIVAL SCORE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; NEW YORK HEART ASSOCIATION CLASS; PACE RISK SCORE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEATTLE HEART FAILURE MODEL; SURVIVAL PREDICTION; SYSTEMATIC REVIEW;

HEART FAILURE; PREDICTION MODELS; PROGNOSIS; SURVIVAL;

AMBULATORY CARE; DECISION SUPPORT TECHNIQUES; HEART FAILURE; HUMANS; MODELS, STATISTICAL; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84887461948     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.000043     Document Type: Article

References (33)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.
2. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J. 2004;25:1614-1619.
3. Goldraich L, Beck-da-Silva L, Clausell N. Are scores useful in advanced heart failure? Expert Rev Cardiovasc Ther. 2009;7:985-997.
4. Ketchum ES, Levy WC. Multivariate risk scores and patient outcomes in advanced heart failure. Congest Heart Fail. 2011;17:205-212.
5. Concato J, Feinstein AR, Holford TR. The risk of determining risk of multivariable models. Ann Intern Med. 1993;118:201-210.
6. Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE. Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker. Heart. 2012;98:683-690.
7. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503-1510.
8. Cui J. Overview of risk prediction models in cardiovascular disease research. Ann Epidemiol. 2009;19:711-717.
9. D'Agostino RB, Byung-Ho N. Evaluation of the performance of survival analysis models: discrimination and calibration measures. In: Balakrishnan N, Rao CR, eds. Handbook of Statistics v23: Advances in Survival Analysis. Amsterdam, The Netherlands: Elsevier; 2004:1-26.
10. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667.
11. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424-1433.
12. Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, Katus HA, Clark AL, Cleland JG, Zugck C. Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status-do we need specificity for sex and beta-blockers? Int J Cardiol. 2011;147:74-78.
13. Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter- defibrillators. Heart Rhythm. 2012;9:42-46.
14. Bilchick KC, Stukenborg GJ, Kamath S, Cheng A. Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol. 2012;60:1647-1655.
15. Zugck C, Krüger C, Kell R, Körber S, Schellberg D, Kübler W, Haass M. Risk stratification in middle-aged patients with congestive heart failure: prospective comparison of the Heart Failure Survival Score (HFSS) and a simplified two-variable model. Eur J Heart Fail. 2001;3:577-585.
16. Koelling TM, Joseph S, Aaronson KD. Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers. J Heart Lung Transplant. 2004;23:1414-1422.
17. Parikh MN, Lund LH, Goda A, Mancini D. Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients >65 years of age with heart failure. Am J Cardiol. 2009;103:998-1002.
18. Gorodeski EZ, Chu EC, Chow CH, Levy WC, Hsich E, Starling RC. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail. 2010;3:706-714.
19. Goda A, Lund LH, Mancini DM. Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation. Am J Cardiol. 2010;105:1439-1444.
20. Goda A, Lund LH, Mancini D. The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy. J Heart Lung Transplant. 2011;30:315-325.
21. Goda A, Williams P, Mancini D, Lund LH. Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM). J Heart Lung Transplant. 2011;30:1236-1243.
22. May HT, Horne BD, Levy WC, Kfoury AG, Rasmusson KD, Linker DT, Mozaffarian D, Anderson JL, Renlund DG. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide. Am J Cardiol. 2007;100:697-700.
23. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC, O'Connor CM, Felker GM. Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299:2533-2542.
24. Kalogeropoulos AP, Georgiopoulou VV, Giamouzis G, Smith AL, Agha SA, Waheed S, Laskar S, Puskas J, Dunbar S, Vega D, Levy WC, Butler J. Utility of the Seattle Heart Failure Model in patients with advanced heart failure. J Am Coll Cardiol. 2009;53:334-342.
25. Giamouzis G, Kalogeropoulos AP, Georgiopoulou VV, Agha SA, Rashad MA, Laskar SR, Smith AL, Butler J. Incremental value of renal function in risk prediction with the Seattle Heart Failure Model. Am Heart J. 2009;157:299-305.
26. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW; REMATCH Investigators. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant. 2009;28:231-236.
27. Perrotta L, Ricciardi G, Pieragnoli P, Chiostri M, Pontecorboli G, De Santo T, Bellocci F, Vitulano N, Emdin M, Mascioli G, Ricceri I, Porciani MC, Michelucci A, Padeletti L. Application of the Seattle Heart Failure Model in patients on cardiac resynchronization therapy. Pacing Clin Electrophysiol. 2012;35:88-94.
28. Haga K, Murray S, Reid J, Ness A, O'Donnell M, Yellowlees D, Denvir MA. Identifying community based chronic heart failure patients in the last year of life: a comparison of the Gold Standards Framework Prognostic Indicator Guide and the Seattle Heart Failure Model. Heart. 2012;98:579-583.
29. Vickers AJ, Cronin AM. Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework. Semin Oncol. 2010;37:31-38.
30. Muntwyler J, Abetel G, Gruner C, Follath F. One-year mortality among unselected outpatients with heart failure. Eur Heart J. 2002;23:1861-1866.
31. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.
32. Janssen KJ, Donders AR, Harrell FE Jr, Vergouwe Y, Chen Q, Grobbee DE, Moons KG. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010;63:721-727.
33. Meinshausen N, Buhlmann P. Stability selection. J R Statist Soc B. 2010;72:417-473.